article thumbnail

India’s Growing Importance in Generic Drug API Manufacturing

Drug Patent Watch

. “India sometimes describes itself as the ‘pharmacy to the world’ because it is a significant global supplier of affordable therapeutics, including many life-saving medicines for chronic conditions.” 2022, October 6). India’s Unique Opportunity and Important Responsibility as “Pharmacy to the World.”

article thumbnail

From siloed data to breakthroughs: multimodal AI in drug discovery

Drug Target Review

He holds a PhD in pharmacy from the University of North Carolina at Chapel Hill, and an MBA from the Rochester Institute of Technology. Nature Medicine, 28, 1656–1661 (2022) [link] Connect on LinkedIn >> Literature Geukes Foppen RJ, Gioia V, Zoccoli A, Velez CN.

Drugs 65
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How the IRA’s Part B Coinsurance Inflation Adjustments Can Raise Seniors’ Drug Costs

Drug Channels

Retail Pharmacy Update 2025: Data, Debate, and Disruption. Well unpack the good, the bad, and the ugly of the pharmacy industryand explore what it means for you. Rather than enjoying stable or reduced costs, some seniors are finding themselves on a financial rollercoaster. Dont miss DCIs next webinar on June 20, 2025 (12:001:30 p.m.

article thumbnail

Vamorolone

New Drug Approvals

79 (2022) 1005–1014. [71] 79 (2022)1005–1014 Bioorg. “FDA Approves Vamorolone for Treatment of Duchenne Muscular Dystrophy in Patients Aged 2 Years and Older” Pharmacy Times. Shale, U.J. Reeves, E.P. Hoffman, K. Nagaraju, J.M. Damsker, J.M. 2020, 117,24285−24293. Alliance 2019, 2,No. e201800186. 2017, 82,11961−11980.

FDA 62
article thumbnail

Syringe services for people who inject drugs are enormously effective, but remain underused

National Institute on Drug Abuse: Nora's Blog

17 In another study, people who received syringes from an SSP were half as likely to dispose of them improperly compared to people who got them from other sources such as pharmacies. 2022 Nov;109:103872. Epub 2022 Oct 3. 2022 May 28;19(1):55. 2022 Dec;54(1):404-412. Int J Drug Policy. doi: 10.1016/j.drugpo.2022.103872.

Drugs 119
article thumbnail

Why 340B Reform Could Happen in 2025 (video)

Drug Channels

Here are some Drug Channels articles with relevant background for the video: The 340B Program Reached $66 Billion in 2023Up 23% vs. 2022: Analyzing the Numbers and HRSAs Curious Actions Follow the 340B Prescription Dollar: How PBMs Profit from 340B Contract Pharmacies Hospitals Are Relying More on PBMs to Manage Manufacturers' 340B Contract Pharmacy (..)

article thumbnail

#WhyIScienceQ&A: A neuroscientist advocates for stepping outside your comfort zone in research

Broad Institute

“I thought that this was where I could learn the most,” said Monti, who is originally from Como, Italy, and completed a master’s degree in pharmacy at the University of Milan. In December 2022, Monti moved to the US and joined the Greka lab as a postdoctoral associate.